BHR Biosynex, a leading provider of point-of-care diagnostic solutions and home-use healthcare products, is pleased to announce the appointment of Adam Martin as Country Manager for the UK & Ireland.
In his role, Adam will be responsible for leading BHR Biosynex’s commercial strategy across the UK and Ireland, overseeing continued growth across point-of-care testing solutions for healthcare professionals alongside the company’s expanding portfolio of home-use, self-care and OTC healthcare products. This includes supporting the ongoing introduction of additional Biosynex Pharma brands into the UK & Ireland market.
Adam brings extensive experience in healthcare sales leadership, market development and strategic partnership building, with a strong track record of driving growth across both professional healthcare and consumer health channels. His expertise spans working closely with clinical stakeholders, community pharmacy, distributors and commercial partners to successfully launch and scale innovative healthcare solutions.
BHR Biosynex is at an exciting stage of development, continuing to strengthen its position in point-of-care diagnostics that support rapid clinical decision-making, while also responding to growing demand for accessible, high-quality home testing and self-care solutions that empower patients to take a more active role in managing their health.
Commenting on the appointment, Oren Bitton, Deputy Chief Executive Officer at BIOSYNEX Group, said: “We are very happy to welcome Adam to BHR Biosynex. His leadership experience and understanding of both professional diagnostics and consumer healthcare make him an excellent fit for our ambitions in the UK & Ireland.
"Adam’s appointment marks an important step as we enter the next chapter of the company’s history. I very much look forward to working with him as we build on our strong foundations and pursue the exciting growth opportunities ahead, across both point-of-care and home-use healthcare solutions.”
In his role, Adam will focus on strengthening customer and partner relationships, expanding BHR Biosynex’s footprint across healthcare, pharmacy and consumer channels, and supporting the successful introduction of new diagnostic and OTC innovations from the wider BIOSYNEX Group.
On joining the company, Adam Martin said: “I am proud to be joining such a great company at a pivotal time and to be leading such an experienced, incredible team. Point of care testing is being utilised across the UK and Ireland healthcare system in increasing varied locations and the addition of the OTC and self-test products compliments the offerings to both healthcare professionals and consumers. We are in for an exciting journey and thank you to Oren, and the UK and Ireland team for their warm welcome.”
